Previous 10 | Next 10 |
CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its partnering conference schedule for October 2022. Compa...
Working together with Denali Therapeutics to accelerate data-driven precision medicine for the PD community Rostock International Parkinson's Disease (ROPAD) Study aims to characterize the genetics of PD to establish a better understanding of the disease progression, diagnosis, an...
The following slide deck was published by Centogene N.V. in conjunction with this event. For further details see: Centogene (CNTG) presents at H.C. Wainwright 24th Annual Global Investment Conference - Slideshow
Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh DAMMAM, SAUDI ARABIA, Sept 8, 2022 - (ACN Newswire) - Dammam Valley, in partnership with other investment partners, and Arcensus GmbH announce the establishment of a high-throughput Saudi-German...
Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics ROSTOCK, Germany & DAMMAM, KSA, Sept 5, 2022 - (...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its investment and partnering conference schedule for Sept...
Gainers: Redbox Entertainment ( RDBX ) +100% . Nano Labs ( NA ) +86% . FaZe ( FAZE ) +42% . Koss Corporation ( KOSS ) +35% . SpringBig Holdings ( SBIG ) +31% . Infrastructure and Energy Alternatives ( IEA ) +31% . ...
Centogene press release ( NASDAQ: CNTG ): Q1 GAAP EPS of -€0.28. Revenue of €10.32M (+3.4% Y/Y). For further details see: Centogene GAAP EPS of -€0.28, revenue of €10.32M
On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business segment in Q1 2022 Positioning Pharma and Diagnostics for post-COVID recovery and growth in 2022 and beyond Reaffirms FY 2022 guidance ...
Centogene (NASDAQ:CNTG) said on Monday it had appointed Miguel Coego Rios as Managing Director and Chief Financial Officer of the Company, effective June 22. Rios joined Centogene as EVP Finance & Legal in February 2022 and served as Interim Chief Financial Officer as of April 1, the...
News, Short Squeeze, Breakout and More Instantly...
TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path), a leader in forming collaborations that accelerate drug development, and Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answer...
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced the voting results of the Company ...
CXApp Inc. (CXAI) is expected to report for quarter end 2024-03-31 Purple Biotech Ltd. (PPBT) is expected to report $-0.15 for Q1 2024 AutoZone Inc. (AZO) is expected to report $35.72 for Q3 2024 Turkcell Iletisim Hizmetleri AS (TKC) is expected to report for Q1 2024 Orkla ASA ADR...